AVGEMSI
NDC 83831-123, Gemcitabine, injection, solution, from Avyxa Pharma, LLC.
- Product NDC
- 83831-123
- Status
- Listed
- Labeler
- Avyxa Pharma, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219920
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83831-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEMCITABINE HYDROCHLORIDE38 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83831-123-01 | 83831012301 | 1 VIAL, MULTI-DOSE in 1 CARTON (83831-123-01) / 26.3 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e11eeff7-bcaf-4bf1-8da8-88138e01af84Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83831-123
Use it
Look up 83831-123 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83831-123 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83831-123. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.